News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Drug Development
Eli Lilly and Company Hails Success of its New R&D Models
February 17, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Pharma Times -- Eli Lilly has been describing two innovative approaches to R&D that are bearing fruit, involving independent funding as well as its internal "lean virtual development organisation".
Twitter
LinkedIn
Facebook
Email
Print
Preclinical
Eli Lilly and Company
MORE ON THIS TOPIC
Schizophrenia
Atai-Partnered Schizophrenia Drug Flunks Mid-Stage Trial
July 28, 2025
·
2 min read
·
Tristan Manalac
Collaboration
Eli Lilly Commits $856M in Biobucks to Gate Bioscience for New Class of Medicines
July 25, 2025
·
1 min read
·
Dan Samorodnitsky
Autoimmune disease
AstraZeneca Claims PIII Win With Nanobody Treatment for Myasthenia Gravis
July 24, 2025
·
2 min read
·
Dan Samorodnitsky
I&I
Novartis Drops up to $1B+ for Drug Discovery Deal With Matchpoint
July 24, 2025
·
2 min read
·
Dan Samorodnitsky
